glp-1 drugs kidney disease GLP1 Receptor Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Kidney Outcomes With Glucagon-Like Peptide-1
Description
If you want to explore whether weight loss medication is right for you, see if you qualify for Noom Med
Personalized Solutions for Managing Interaction Risks When it comes to managing GLP-1 therapy alongside other medications, theres no universal formula
However, rigorous clinical trials are needed to firmly establish efficacy, dosing, safety, and comparative effectiveness before considering GLP-1RAs a viable novel approach
10.1016/j.cmet.2019.07.013
Second, and more fundamentally, it is not clear that these drugs cross the blood-brain barrier in the classical sense at all
J Control Release 2020;325:11120.PubMed 16
